Nuo Therapeutics Inc. (AURX)

Overview

Nuo Therapeutics, Inc. is a pioneering firm in the field of regenerative therapies, committed to the development, commercialization, and distribution of cell-based technologies designed to leverage the human body's innate regenerative capabilities to stimulate natural healing processes. With its operations primarily based in the United States, the company stands at the forefront of offering innovative solutions for the chronic wound care market. Initially founded under the name Cytomedix, Inc., the organization underwent a rebranding to Nuo Therapeutics, Inc. in November 2014, highlighting its evolution and focused commitment to therapeutic advancements. Since its inception in 1998, Nuo Therapeutics has been headquartered in Houston, Texas, symbolizing its strong foundation and continuous growth in the regenerative medicine sector.

Products and Services

• Aurix System

The Aurix System represents Nuo Therapeutics, Inc.'s flagship offering, embodying the company's dedication to harnessing the body's healing capacity for chronic wound care. This innovative system utilizes a patient's own blood to create a platelet-rich therapy, specifically engineered to accelerate the healing process for chronic wounds. The technology behind the Aurix System isolates and concentrates key regenerative components from autologous blood, making it a powerful tool for the treatment of various types of chronic wounds. It sees widespread application in hospital outpatient wound care clinics and by private practice physicians, marking it as a critical advancement in improving patient outcomes in the wound care space.